Deutsche Bank’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History
Bought
Maintained
Sold
Other funds holding MBVX
BCM
BCI
Deutsche Bank's MBVX Position: Q1 2018 in Review
Deutsche Bank sold out of MABVAX THERAPEUTICS HLDGS INC (MBVX) in Q1 2018, closing a stake of 1 share.
Deutsche Bank first reported a position in MBVX in Q3 2016 and held it in 6 quarters. The position peaked at $0 in Q4 2017. 11 funds tracked by Wall St. Rank hold MBVX as of Q1 2018.
- Deutsche Bank reported no remaining MABVAX THERAPEUTICS HLDGS INC position as of Q1 2018 after selling out during the quarter.
- Deutsche Bank sold 1 MABVAX THERAPEUTICS HLDGS INC share in Q1 2018.
- Deutsche Bank first reported a position in MABVAX THERAPEUTICS HLDGS INC in Q3 2016 and held it in 6 quarters.
- Deutsche Bank's MABVAX THERAPEUTICS HLDGS INC position peaked at $0 in Q4 2017.
- 11 funds tracked by Wall St. Rank held MABVAX THERAPEUTICS HLDGS INC as of Q1 2018.
Based on Deutsche Bank's 13F filing for Q1 2018, filed 15 May 2018.